ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Cincinnati, OH, USA:

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Cincinnati, Ohio, United States and 40 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Concord, Ohio, United States and 49 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Cincinnati, Ohio, United States and 187 other locations

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors ...

Enrolling
Type 2 Diabetes
Cortisol Excess
Drug: clofutriben
Drug: Placebo

Phase 2

Sparrow Pharmaceuticals

Cincinnati, Ohio, United States and 45 other locations

study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Overweight
Other: Placebo
Drug: Petrelintide

Phase 2

Zealand Pharma
Zealand Pharma

Cincinnati, Ohio, United States and 48 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Cincinnati, Ohio, United States and 39 other locations

This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when comp...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: NNC0662-0419

Phase 2

Novo Nordisk
Novo Nordisk

Dayton, Ohio, United States and 62 other locations

Locations recently updated

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: LY3457263
Drug: Placebo

Phase 2

Lilly
Lilly

Dayton, Ohio, United States and 60 other locations

of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: LY3841136

Phase 2

Lilly
Lilly

Cincinnati, Ohio, United States of America and 51 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Cincinnati, Ohio, United States of America and 100 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems